152 related articles for article (PubMed ID: 13366721)
1. Novobiocin for infections due to Micrococcus pyogenes.
GERACI JE; HEILMAN FR; MARTIN WJ; NICHOLS DR; WELLMAN WE
J Am Med Assoc; 1956 Nov; 162(12):1150-3. PubMed ID: 13366721
[No Abstract] [Full Text] [Related]
2. Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns.
LOWBURY EJ
Lancet; 1957 Aug; 273(6990):305-10. PubMed ID: 13507637
[No Abstract] [Full Text] [Related]
3. Novobiocin in the treatment of surgical infections due to staphylococci and other gram-positive bacteria.
RUTENBURG AM; SHAPIRO P; SCHWEINBURG F
N Engl J Med; 1956 Aug; 255(7):325-30. PubMed ID: 13348863
[No Abstract] [Full Text] [Related]
4. Novobiocin; a limited bacteriologic and clinical study of its use in forty-five patients.
NICHOLS RL; FINLAND M
Antibiotic Med Clin Ther (New York); 1956 Apr; 2(4):241-57. PubMed ID: 13303120
[No Abstract] [Full Text] [Related]
5. Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains.
BARBER M; CSILLAG A; MEDWAY AJ
Br Med J; 1958 Dec; 2(5109):1377-80. PubMed ID: 13596614
[No Abstract] [Full Text] [Related]
6. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics.
WISE RI; VOIGT AE; COLLIN MV; CRANNY CL
AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420
[No Abstract] [Full Text] [Related]
7. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
NOYES HE; NAGLE SC; SANFORD JP; ROBBINS ML
Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
[No Abstract] [Full Text] [Related]
8. [Septicemia due to Staphylococcus albus haemolyticus].
KEYMER E
Bol Soc Chil Obstet Ginecol; 1951 Sep; 16(6):155-62. PubMed ID: 14916023
[No Abstract] [Full Text] [Related]
9. Combined antibiotic therapy in serious infections caused by drug-resistant staphylococci (1956-1957).
JAWETZ E
AMA Arch Intern Med; 1959 Feb; 103(2):289-307. PubMed ID: 13616766
[No Abstract] [Full Text] [Related]
10. [Enterotoxicosis due to Micrococcus pyogenes aureus after sanclomycin treatment; cure by erythromycin].
BERNAY P
Arch Mal Appar Dig Mal Nutr; 1956 Oct; 45(10):276-7; discussion, 277-8. PubMed ID: 13373476
[No Abstract] [Full Text] [Related]
11. Recurrent Staphylococcus aureus pneumonia and empyema treated with novobiocin; review of the literature, with report of a case.
SCHNECK H
J Pediatr; 1957 May; 50(5):570-8. PubMed ID: 13417022
[No Abstract] [Full Text] [Related]
12. Ristocetin and the Staphylococcus; observations of effects and side-effects in seventeen cases of staphylococcic pneumonia.
CALVY GL; SCHUMACHER LR
J Am Med Assoc; 1958 Jul; 167(13):1584-6. PubMed ID: 13563145
[No Abstract] [Full Text] [Related]
13. Antibiotic-resist micrococcic infections: guest editorial.
FINLAND M
J Am Med Assoc; 1955 May; 158(3):188-90. PubMed ID: 14367069
[No Abstract] [Full Text] [Related]
14. Streptonivicin (albamycin): a new antibiotic; preliminary report.
MARTIN WJ; HEILMAN FR; NICHOLS DR; WELLMAN WE; GERACI JE
Proc Staff Meet Mayo Clin; 1955 Nov; 30(23):540-51. PubMed ID: 13273516
[No Abstract] [Full Text] [Related]
15. [Surgical staphylococcal infections & antibiotics].
LINDER F
Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1957; 287():74-9. PubMed ID: 13526359
[No Abstract] [Full Text] [Related]
16. Some recent observations on staphylococcal infections in relation to antibiotic therapy.
FINLAND M; JACKSON GG; KASS EH; HAIGHT TH; WOMACK CR
Trans Assoc Am Physicians; 1951; 64():343-4. PubMed ID: 14884268
[No Abstract] [Full Text] [Related]
17. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
RANTZ LA; RANDALL E; THUM L; BARKER LF
Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
[No Abstract] [Full Text] [Related]
18. [Some new aspects of staphylococcic infections and their therapy].
TRAISSAC FJ
J Med Bord; 1952 Oct; 129(10):955-64. PubMed ID: 13023193
[No Abstract] [Full Text] [Related]
19. Indications for the usefulness of triacetyloleandomycin in epidemic staphylococcal infections.
ENGLISH AR; FINK FC
Antibiot Chemother (Northfield); 1958 Aug; 8(8):420-3. PubMed ID: 24544893
[No Abstract] [Full Text] [Related]
20. [Staphylococcal pneumonia in adults].
Tetreault A
Laval Med; 1957 Feb; 22(2):191-8; discussion, 198-9. PubMed ID: 13407142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
